Biolojic Design Ltd.

Also on record

Records under this name other than the patents Biolojic Design Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 9 of 9 · Back to Biolojic Design Ltd.

Patent	Title	Status	Expires
17/885,564	Computer Assisted Antibody Re-Epitoping Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
18/262,419	Dual Binding Antibodies, Methods of Producing Dual Binding Antibodies, and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
18/404,093	Methods of Use of ANTI-IL-2 Antibodies Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
18/431,983	Methods of Use of ANTI-IL-2 Antibodies Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
19/075,047	Engineered ANTI-IL-2 Antibodies Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
19/345,303	ANTI-IL-2 Antibody Combinations and Methods of Use Thereof now held by Aulos Bioscience, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
19/345,459	ANTI-IL-2 Antibody Combinations and Methods of Use Thereof now held by Aulos Bioscience, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
19/381,194	ANTI-IL-2 Antibody Combinations and Methods of Use Thereof now held by Aulos Bioscience, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.
19/700,775	Engineered Dual Binding Antibodies and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied.	Pending	Term is not computable until grant, so no date is shown and no estimate is implied.